Evidence map›Paper›PMID 41530858›Full record

ReviewChinese medicine2026

Supramolecular self-assembly in Traditional Chinese Medicine: molecular mechanisms, material basis of decoction efficacy, compatibility interpretation, and biomedical applications.

Yinan Wang, Qiang Xiao, Can Liu, Wenjun He, Xinning Ren, Meifeng Xiao, Qijun He, Xue Pan, Fuyuan He

Abstract readReview
In one paragraph

Review in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yinan WangSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Qiang XiaoSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Can LiuSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Wenjun HeSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Xinning RenSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Meifeng XiaoSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Qijun HeSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, 410208, China.
Xue PanSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. 003920@hnucm.edu.cn.
Fuyuan HeSchool of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China. pharmsharking@163.com.

Funding

Hunan University of Chinese Medicine (2022) Special Project for Tackling Key Issues No.2022-12-27-1National Natural Science Foundation of China No.82274215Natural Science Foundation of Hunan Province No.2025JJ80145Young Scientists Fund of the National Natural Science Foundation of China No.82404815
6 · The paper itself

Abstract

Traditional Chinese Medicine (TCM), characterized by multi-component and multi-target pharmacological effects, boasts millennia of clinical application. The complexity of its pharmacological material basis extends beyond individual chemical components to include physical structures formed among constituents. Supramolecular chemistry offers a new perspective for elucidating this basis. This review systematically summarizes recent advances in supramolecular self-assemblies within TCM, focusing on molecular formation mechanisms, key chemical component characteristics driving assembly, their roles in decoctions, and the supramolecular basis for "efficacy enhancement and toxicity reduction" in compatibility theory. The biomedical applications of supramolecular self‑assemblies in TCM are also reviewed. Ultimately, this work aims to offer new insights into TCM's material basis, clarify compatibility mechanisms, advance the supramolecular interpretation of TCM theories, and provide perspectives for TCM modernization and drug development.

Indexed as

Biomedical applicationsCompatibility interpretationEfficacy enhancement and toxicity reductionPharmacological material basisSupramolecular self-assemblyTraditional Chinese Medicine

Identifiers

PMID41530858
PMCPMC12797908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.